surpass trial tirzepatide Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 Latest Data From SURPASS Trials

And the biggest price drop in pharma history just happened

GLP-1 therapy represents one of the most significant advancements in modern metabolic medicine

Yu H, Lin L, Zhang Z, Zhang H, Hu H

When to seek medical advice : Patients should contact their GP or prescriber if they experience: Severe or persistent nausea, vomiting, or abdominal pain (particularly if severe and radiating to the back, which could indicate pancreatitis) Signs of dehydration (dark urine, dizziness, reduced urination) Symptoms of gallstones (right upper quadrant pain, jaundice) Any concerning symptoms while taking weight loss medications If you experience side effects from Wegovy, report them through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)